Safety concerns remain for developing replicating vectors based on the pathogen human immunodeficiency virus type 1.
Ben Berkhout
Advertisement
Articles by Ben Berkhout
Advertisement
Latest Updated Articles
Evolution of Live-Attenuated HIV VaccinesPublished: January 2nd 2011 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
2
From Parm to Pharm: Avantor, p-Chip Bring COI Compliance to Clinical Consumables
3
Challenges, Innovations, and Future Outlook of Biologics Formulations
4
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
5
